BioLargo Files DEF 14A, Details Executive Pay & Shareholder Votes
Ticker: BLGO · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 880242
| Field | Detail |
|---|---|
| Company | Biolargo, Inc. (BLGO) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
BioLargo's DEF 14A is out! Get the scoop on exec pay and what you'll be voting on June 19th.
AI Summary
BioLargo, Inc. filed its DEF 14A on April 25, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2024. The filing provides information on the company's board of directors and key executive officers, including their compensation packages and stock ownership. It also outlines proposals to be voted on at the upcoming annual meeting of stockholders, scheduled for June 19, 2025.
Why It Matters
This filing is crucial for investors as it reveals how executive compensation is structured and provides details on important shareholder votes that could impact the company's future direction.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specific proposals and compensation details can reveal underlying financial health and strategic decisions that may carry risk.
Key Numbers
- 20250619 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
- 2024-12-31 — Fiscal Year End (The compensation and financial data reported cover this period.)
Key Players & Entities
- BIOLARGO, INC. (company) — Filer
- NUWAY MEDICAL INC (company) — Former Company Name
- NUWAY ENERGY INC (company) — Former Company Name
- LATIN AMERICAN CASINOS INC (company) — Former Company Name
- 20250425 (date) — Filing Date
- 20250619 (date) — Annual Meeting Date
- 2024-12-31 (date) — Fiscal Year End
FAQ
What is the primary purpose of this DEF 14A filing for BioLargo, Inc.?
The primary purpose is to provide shareholders with information regarding executive compensation, corporate governance, and proposals to be voted on at the annual meeting of stockholders.
When is the scheduled date for BioLargo, Inc.'s annual meeting of stockholders?
The annual meeting of stockholders is scheduled for June 19, 2025.
What fiscal year does the compensation information in this filing primarily cover?
The compensation information primarily covers the fiscal year ending December 31, 2024.
Has BioLargo, Inc. operated under any previous names?
Yes, BioLargo, Inc. has operated under the former names NUWAY MEDICAL INC, NUWAY ENERGY INC, and LATIN AMERICAN CASINOS INC.
What is the company's principal business address as listed in the filing?
The company's principal business address is 14921 Chestnut St., Westminster, CA 92683.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding BIOLARGO, INC. (BLGO).